His research
At the
Institut de Pharmacologie Moléculaire et Cellulaire (Université Côte d'Azur, CNRS, INSERM),
Jacques Barik studies
the molecular mechanisms and events
cular mechanisms and events underlying the impact of nicotine on the brain , with a view to developing treatments to aid smoking cessation.
Smoking is
one of the leading causes of preventable death, regardless of gender, and nicotine dependence is associated with multiple psychiatric comorbidities. In addition to continued high cigarette consumption,
vaping has become an extremely popular alternative method of nicotine absorption, particularly among teenagers. Nicotine dependence therefore remains a major public health problem.
This project
focuses particularly on adolescence, a key period in the development of addiction. Indeed, among smokers, those who started smoking during adolescence are more likely to become addicted in adulthood.
The brain undergoes major transformations, favoring the emergence of adult behaviors.
Nicotine disrupts this maturation process, making adolescents more susceptible to addiction.
The aim of the NICADO project is to
explore nicotine-induced brain changes and understand the mechanisms underlying addiction. In particular, we are focusing on dopaminergic neurons in
the ventral tegmental area (VTA), a key brain region involved in
motivation, pleasure and emotion. These nicotine-sensitive neurons are often impaired in psychiatric disorders such as anxiety, depression and decision-making disorders.
The main objectives of the project are :